CRISPR‐mediated knockout of DRD1 in lung cancer cell lines significantly increases cell proliferation (Fig. 2A, Fig. S3A–C), as does shRNA‐mediated stable DRD1 knockdown (Fig. S4B,C). Here, DRD1 is linked to lung cancer.